F064 The Pregnant Pause: How to Evaluate and Treat Your Pregnant Patients
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Dermatologists face multiple challenges when evaluating and treating the pregnant patient. Treatment of acne, atopic dermatitis and psoriasis is difficult; risks to the fetus limit the number of evidence-based studies concerning drug therapy. Concerning melanocytic lesions, do nevi change during pregnancy, and if melanoma is diagnosed, is there a poor prognosis? Infections and infestation may present a risk for mother and fetus, and treatment options may be limited. Several dermatoses are specific for pregnancy; early recognition and management may be important to prevent adverse effects on the fetus and/or mother.
LEARNING OBJECTIVES
Develop treatment plans for pregnant patients with common dermatologic diagnoses.
Evaluate and manage melanocytic lesions in the pregnant patient.
Recognize and treat specific dermatoses of pregnancy.
SCHEDULE
11:30 PM
Treatment of Psoriasis in the Pregnant Patient
Bruce Elliot Strober, MD, PhD, FAAD
11:50 PM
Treatment of Acne in the Pregnant Patient
Jonette Elizabeth Keri, MD, PhD, FAAD
12:10 AM
Specific Dermatoses of Pregnancy
Miriam Keltz Pomeranz, MD, FAAD
12:30 AM
Treatment of infections and Infestations in the Pregnant Patient
Jenny Eileen Murase, MD, FAAD
12:50 AM
Evaluation and Management of Nevi and Melanoma in the Pregnant Patient
Jane Margaret Grant-Kels, MD, FAAD
1:10 AM
Treatment of Atopic Dermatitis in the Pregnant Patient
Marcia S. Driscoll, MD, FAAD
SPEAKERS
Marcia S. Driscoll, MD, FAAD
Jane Margaret Grant-Kels, MD, FAAD
Jonette Elizabeth Keri, MD, PhD, FAAD
Jenny Eileen Murase, MD, FAAD
Miriam Keltz Pomeranz, MD, FAAD
Bruce Elliot Strober, MD, PhD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Marcia S. Driscoll, MD, FAAD
UpToDate, Inc – Other(Honoraria);
Jane Margaret Grant-Kels, MD, FAAD
DermaSensor Inc – Advisory Board(No Compensation Received); VeraDermics Inc. – Board of Directors(No Compensation Received), Founder(No Compensation Received);
Jonette Elizabeth Keri, MD, PhD, FAAD
Almirall – Consultant(Fees); Foamix Pharmaceuticals Ltd – Speaker/Faculty Education(Honoraria); Galderma Mexico – Speaker(Honoraria); Galderma USA – Investigator(Grants/Research Funding), Investigator(No Compensation Received); Ortho Dermatologics – Advisory Board(Honoraria); VYNE Therapeutics – Speaker/Faculty Education(Honoraria);
Jenny Eileen Murase, MD, FAAD
AbbVie – Consultant(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Regeneron – Speaker/Faculty Education(Honoraria); Sanofi – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); UCB – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); UpToDate – Consultant(Honoraria);
Miriam Keltz Pomeranz, MD, FAAD
Incyte Corporation – Consultant(No Compensation Received); Procter & Gamble Company – Advisory Board(Fees); UpToDate, Inc – Other(Patent royalties or other compensation for Intellectual Property Rights);
Bruce Elliot Strober, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen-Ortho Inc. – Advisory Board(Honoraria), Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Union Therapeutics – Consultant(Fees);